Role of platelet rich plasma in Osteoarthritis knee

A randomized control trial evaluating role of cellular therapy in osteoarthritis of knee - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058367

Enrollment

Registered

2023-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: patient treated with Bone marrow aspirate concentrate: patients managed with Bone marrow aspirate concentrate at 1 month ,3 months , 6 months. Control Intervention1: Patients treated w

Eligibility

Inclusion criteria

Inclusion criteria: All patients with Grade 1 and grade 2 osteoarthritis knee

Exclusion criteria

Exclusion criteria: Co morbid conditions like sickle cell anaemia , blood dyscrasias.

Design outcomes

Primary

Measure	Time frame
Platelet rich plasma & bone marrow aspirate concentrate will heal faster in grade 1 and grade 2 osteoarthritisTimepoint: Platelet rich plasma & bone marrow aspirate concentrate will heal faster in grade 1 and grade 2 osteoarthritis	—

Secondary

Measure	Time frame
healing osteoarthritis knee with PRP & BMACTimepoint: serial USG knee was done at 1 month,3 months & 6 months	—

Countries

India

Contacts

Public ContactSandeep Shrivastava

Jawaharlal Nehru Medical College,wardha

drsandeepshrivastava@gmail.com9765404068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026